02 May Xylem Reports First Quarter 2024 Results and Raises Full-Year Guidance
Orders of $2.2 billion, up 43% on a reported basis and 3% organically Revenue of $2.0 billion, up 40% on a reported basis and 7% organically Earnings per share of $0.63, up 17%; $0.90 on an adjusted basis, up 14% Raising full-year revenue guidance...